U.S. Medical Marijuana Patients Near 4 Million, New Study Finds

October 1, 2026

Photo via Unsplash.

Nearly four million Americans now carry a medical marijuana card. That's the headline figure in a new research letter tracking patient registries across the country, but the more interesting number might be the one researchers calculated for the first time: an estimated 110,000 registered caregivers -- the people who legally help patients grow, obtain, or manage their cannabis when they can't do it themselves. Combine that with a count of roughly 35,000 physicians and other clinicians now authorized to recommend cannabis, and you get the fullest picture yet of the infrastructure propping up medical cannabis in the United States, nearly a decade after most of these programs took their modern shape.

The data comes from an analysis of state patient registries and clinician databases, and it tells a story that's more complicated than simple growth. Patient numbers exploded, then plateaued, then in some states started shrinking -- even as the list of conditions that qualify someone for a card kept expanding. Understanding why requires looking at what happened state by state, not just at the national total.

How Patient Numbers Exploded Since 2016

The raw growth is hard to overstate. In 2016, state registries counted 746,975 medical cannabis patients nationwide. By 2024, that figure had climbed to 3,920,592 -- a 425% increase in less than a decade. Adjusted for population, the patient rate per 10,000 people grew from 70.9 to 195.9, a jump of 176.3%. That's not a rounding error or a statistical quirk; it reflects millions of real people enrolling in programs that, in many states, barely existed a generation ago.

As of June 2026, medical cannabis is legal in some form in 41 states plus Washington, DC, leaving a shrinking handful of holdouts concentrated mostly in a few regions of the South and parts of the Midwest. Layered on top of that, 24 states and DC have also legalized recreational cannabis for adults 21 and older, which fundamentally changes the math on who bothers registering as a patient at all. When anyone can walk into a dispensary and buy flower or edibles without a doctor's note, the incentive to maintain a medical card shifts -- it's no longer the only legal path to access, just one option among several.

What the topline numbers obscure is timing. Most of that 425% surge happened in the years immediately following 2016, as newer programs ramped up and existing ones expanded their qualifying conditions and patient outreach. Growth was never steady year over year -- it was front-loaded, with the curve flattening noticeably as the 2020s progressed. That leveling-off is arguably the more consequential trend for anyone trying to understand where medical cannabis is headed next.

Why Registration Growth Has Stalled Since 2022

Here's the part that should catch the attention of state regulators: in 15 of 19 jurisdictions researchers examined, patient enrollment actually dropped after recreational dispensaries opened their doors. Colorado, Oregon, and Washington all saw this pattern play out, and it's not hard to understand why once you consider what a medical card actually costs someone in time and money.

Registering as a medical patient typically means paying a licensing fee, securing a physician recommendation (sometimes an out-of-pocket telehealth visit), and renewing that paperwork annually or biennially. In a state where recreational sales are legal and widely available, a lot of patients are apparently deciding that hassle isn't worth it anymore, especially if their main benefit was tax savings on a handful of purchases a year. Privacy concerns play a role too -- some patients simply don't want their name on a state registry if they don't have to be there.

That creates a genuine blind spot for anyone trying to measure actual medical cannabis use. A person managing chronic pain or PTSD with cannabis they bought at a recreational shop isn't showing up in any patient registry, even though their use is functionally medical. The real number of Americans using cannabis therapeutically is almost certainly higher than 3.9 million once you account for this shadow population -- it's just invisible to the data collection methods states currently use.

This matters beyond academic curiosity. States that tie tax exemptions, higher possession limits, or workplace protections to medical card status are essentially building policy on a shrinking and increasingly unrepresentative sample of the people actually using cannabis for health reasons.

Chronic Pain Still Dominates Qualifying Conditions

Chronic pain's share of patient-reported qualifying conditions fell sharply from 64.5% in 2016 to 31.9% in 2024, as PTSD (28.6%) and anxiety (16.7%) emerged as major conditions, reflecting a diversification of reasons patients cite for medical marijuana use.

Chronic pain has been the single most common qualifying condition in both years researchers studied, but its dominance has slipped considerably. In 2016, chronic pain accounted for 64.5% of all qualifying conditions reported across state registries. By 2024, that share had fallen to 31.9% -- still the leading category, but no longer anything close to a majority.

What's filling the gap tells its own story. PTSD climbed to become the second most common qualifying condition by 2024, cited in 28.6% of cases, with anxiety close behind at 16.7%. Neither of these conditions carried anywhere near that weight in the early years of modern medical cannabis programs, when most state laws were written narrowly around pain, cancer, and a short list of other physical diagnoses.

The shift reflects a broader legislative trend: state lawmakers have steadily expanded their qualifying condition lists to include a wider range of mental health diagnoses, often in response to patient advocacy and growing public acceptance of cannabis as a tool for managing conditions like anxiety and trauma-related disorders. Some states added PTSD specifically in response to veterans' advocacy campaigns, while others broadened their lists more generally to include anxiety disorders alongside pain and seizure conditions.

It's worth noting this data reflects what conditions patients report when registering, not necessarily clinical evidence of efficacy for any given diagnosis -- research on cannabis and anxiety, in particular, is still unsettled and sometimes contradictory. But as a measure of how state policy has evolved, the shift from a pain-dominated model toward one that includes mental health conditions is unmistakable.

35,000 Doctors and a New Count of Caregivers

Photo via Pexels.

Behind every patient registration is a clinician willing to sign off on it, and that pool has grown too, though less dramatically than the patient count. The number of authorizing clinicians rose from roughly 29,500 in 2020 to more than 35,000 by 2024 -- about a 19% increase. Researchers also found a clear split in participation rates: states running medical-only programs, without a parallel recreational market, had substantially lower rates of clinician participation than states where medical and recreational cannabis coexist.

The same research produced something that hadn't existed before in any systematic way -- a nationwide estimate of medical cannabis caregivers. These are the people, often family members, who are legally registered to help a patient obtain, grow, or manage their cannabis, typically because the patient is a minor, elderly, or otherwise unable to handle it themselves. The researchers put that number at nearly 110,000 people, which means caregivers outnumber authorizing clinicians by roughly three to one -- a workforce that's largely gone uncounted until now.

Separately, a White House action from December 2025 cited figures from the Department of Health and Human Services putting the clinician count above 30,000 across 43 jurisdictions, serving more than 6 million patients. That patient figure is notably higher than the 3.9 million found in the registry-based research, and the discrepancy likely comes down to counting methods -- HHS may be including recreational users who report medical reasons for use, while the registry data only counts people formally enrolled in state medical programs. Either way, both figures point toward a clinician base that has grown steadily even as patient registration growth has slowed.

What the Numbers Mean for Patients and Policy

Photo via Pexels.

The research driving these figures comes from a team led by Kevin Boehnke at the University of Michigan, building on earlier work the same group published in the Annals of Internal Medicine in 2022 and 2024 tracking these trends since 2016. That continuity matters -- it means we're looking at a consistent methodology applied over nearly a decade, rather than a one-off snapshot that's hard to compare against anything else.

Taken together, the numbers suggest medical cannabis programs are maturing rather than fading into irrelevance as recreational markets spread. Patient growth has slowed, and in some states reversed, but clinician participation keeps climbing and the range of qualifying conditions keeps broadening. That's a program evolving, not one disappearing.

For lawmakers in states that still restrict cannabis to medical use only, the lower clinician participation rates documented here point to a practical problem: a medical program only works if patients can actually find a doctor willing to recommend cannabis. States without a recreational market to drive broader normalization may need to look at why clinician participation lags and whether licensing, training, or liability concerns are keeping doctors on the sidelines.

The gap between the registry-based 3.9 million patient estimate and the HHS figure of more than 6 million is itself a lesson. Measuring medical cannabis use nationally remains genuinely messy, dependent on which data source you trust and what counting method it uses. Anyone citing a single national number should treat it as a rough estimate, not a precise census.

None of these national trends tell you much about what's actually required in your own state, and that's the detail that matters most if you're considering medical cannabis for yourself or a family member. Qualifying conditions, renewal timelines, licensing fees, and even whether a medical card gets you anything beyond what a recreational dispensary offers vary enormously from one state to the next -- and these rules change often enough that last year's information can be out of date.

Before assuming your state follows the national pattern of declining enrollment or expanding mental health coverage, check your own program's current rules directly through your state health department. Cannabis remains illegal under federal law regardless of any state's medical program, so the practical protections and benefits you get depend entirely on where you live. The research here is useful for understanding the forest, but patients still have to navigate one specific tree.